Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. No visible changes to study details or page layout were observed.SummaryDifference0.0%

- Check27 days agoChange DetectedMinor formatting and textual edits across sections with no changes to core trial data (eligibility criteria, outcomes, or participating sites). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page shows a new Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be a minor site revision and does not alter study content or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Study Locations section was updated with new sites across the US, Canada, Spain, and several European and former Soviet regions, and some previously listed locations were removed.SummaryDifference2%

- Check91 days agoChange DetectedAdded a note that PubMed publications are auto-filled from PubMed and updated the revision to v3.3.2, replacing the previous PubMed publication description and revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.